-
-
-
-
-
-
-
Precipio Announces Q1-2026 Shareholder Update Call
-
-
-
-
-
-
-
Precipio Announces Q3-2025 Shareholder Update Call
-
-
-
-
-
-
-
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
-
-
-
-
-
-
-
Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping
-
-
-
-
-
-
-
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
-
-
-
-
-
-
-
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
-
-
-
-
-
-
-
Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023
-
1,218,206 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

